trial · primary record
Navlimetostat
Solid Tumors
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 254 |
| Primary completion | 2032-05-20 |
| Primary endpoint | Part 1: Number of participants who achieve Objective Response (OR) |
| Registry ID | NCT07492680 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:57.249Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07492680
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Navlimetostat · compound